In 2020, OMF secured a $1 million grant to launch the first year of an international, multi-year study across the five OMF funded Collaborative Research Centers (CRC). The aim of this study is to examine Post-COVID Syndrome transitioning to ME/CFS. We are actively working to raise an additional $2 million for years two and three of the study. I am pleased to share with you an update on the first phase of this groundbreaking — and urgently needed — research project.
The COVID-19 pandemic
It feels like it’s coming to an end
But millions are still sick.
And they’re waiting for answers.
In mid-2020, Open Medicine Foundation (OMF) launched a three-year study to find answers. We’re leading a large-scale international study following the potential conversion of Post-COVID Syndrome, also known as Long-COVID, to Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS), a chronic, life-altering disease. This study is an unprecedented opportunity to find ME/CFS drug treatments and prevention strategies at an accelerated pace.
As leaders of the largest worldwide nonprofit effort to diagnose, treat, and prevent ME / CFS and related complex diseases, such as Post Treatment Lyme Disease Syndrome and Fibromyalgia, we know one thing to be true: If we don’t do the research now, millions will be left behind. Join us in our mission to find the answers.